|Title:||Anti-Albuminuric Effects of the Angiotensin AT1 Receptor Blocker Telmisartan in Hypertensive Patients||Authors:||Rodriguez-Perez, Jose C.
Garcia-Bello, Miguel A.
Novoa-Mogollon, Francisco J.
Prevention, et al
|Issue Date:||2011||Publisher:||1064-1963||Journal:||Clinical and Experimental Hypertension||Abstract:||We evaluated the anti-hypertensive and anti-albuminuric effect of the angiotensin receptor blocker telmisartan alone and in combination with torasemide and amlodipine. Patients were hypertensive, both diabetics and non-diabetics with persistent microalbuminuria. Our primary endpoint was a change in microalbuminuria levels, while the secondary endpoints were changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), serum creatinine levels, and glomerular filtration rate. After the 16-week treatment period, the patients significantly reduced microalbuminuria levels (76.4 +/- 52.4 mu g/min; p < 0.001), SBP (16.4 +/- 8.7 mmHg; p < 0.001) and DBP (17.7 +/- 5.9 mmHg; p < 0.001). Both diabetics and non-diabetics showed an identical pattern of significance with respect to the whole population. Systolic blood pressure, DBP, and microalbuminuria were significantly reduced as a consequence of therapy, both in diabetics and non-diabetics.||URI:||http://hdl.handle.net/10553/53000||ISSN:||1064-1963||DOI:||10.3109/10641963.2011.561900||Source:||Clinical And Experimental Hypertension[ISSN 1064-1963],v. 33 (8), p. 506-510|
|Appears in Collections:||Artículos|
checked on Nov 19, 2023
WEB OF SCIENCETM
checked on Oct 2, 2022
checked on Jul 22, 2023
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.